The highly anticipated SupplySide Global 2026 event culminated in a vibrant showcase of cutting-edge ingredient innovation, with three distinct products emerging as the victors of the prestigious Ingredient Idol competition. Held against the backdrop of a bustling exhibition floor and a standing-room-only audience, the competition highlighted groundbreaking advancements in the adaptogen, biotics, and longevity sectors of the dietary supplement industry. Devon Gholam, an esteemed editor at SupplySide Supplement Journal, expertly guided the proceedings, introducing a curated selection of finalists who presented their revolutionary ingredients to a panel of discerning industry experts and an engaged audience. While the applause of attendees offered an early indication of popular favor, the ultimate decision rested with the panel, comprising industry veterans Diana Morgan, Doug Lynch, and David Foreman, who meticulously evaluated each submission based on scientific merit, market potential, and innovative application.
The Ingredient Idol competition, a cornerstone of SupplySide Global’s commitment to fostering innovation, has become a critical platform for emerging ingredients to gain industry recognition and accelerate their market penetration. This year’s event, held at a pivotal moment for the supplement industry, focused on categories experiencing exponential growth and consumer interest. Adaptogens, known for their stress-modulating properties, continue to captivate the market; biotics, encompassing probiotics, prebiotics, and postbiotics, are revolutionizing gut health and beyond; and longevity ingredients are at the forefront of a burgeoning wellness movement focused on extending healthspan. The finalists, representing the vanguard of research and development in these dynamic fields, presented compelling cases for their ingredients, underscoring the industry’s relentless pursuit of scientifically validated solutions for improved health and well-being.
Adaptogen Winner: Xeya Modern Shatavari Redefines Stress Management and Women’s Health
In the highly competitive adaptogen category, Xeya Modern Shatavari, a product of Laila Nutra and distributed by NXT USA, not only secured the coveted top prize but also garnered overwhelming support from the audience, solidifying its position as a dual winner. This standardized extract of Asparagus racemosus root is distinguished by its high concentration of 15% shatavarins, a key bioactive compound. Emerging research presented during the competition highlights Xeya’s significant benefits for women navigating the physiological and emotional shifts of perimenopause, a phase of life characterized by hormonal fluctuations and a range of associated symptoms. Furthermore, preliminary studies suggest efficacy in managing polyendocrine metabolic ovarian syndrome (PMOS), a complex hormonal disorder.
Todd Runestad, Chief Storytelling Officer at NXT USA, articulated the ingredient’s unique value proposition, stating, "Xeya is a hormonal adaptogen, and it’s the lowest dose because it has the highest concentration of shatavarins." This potent standardization translates into exceptional versatility, allowing for seamless integration into a wide array of delivery formats, from capsules and powders to functional beverages and topical applications. The scientific backing, particularly its targeted action on hormonal balance, positions Xeya Modern Shatavari as a significant advancement in the adaptogen landscape. Industry analysts anticipate that this dual recognition will catalyze significant market traction, drawing attention from formulators seeking scientifically validated solutions for women’s health and stress management. The ingredient’s ability to address multiple health concerns with a single, highly concentrated extract is expected to drive demand and foster new product development across the supplement market.
Biotics Winner: effera Lactoferrin Pioneers a New Era in Gut Health and Immune Support
The biotics category witnessed the triumphant emergence of effera, a bioidentical human lactoferrin ingredient developed by Helaina. This innovative product captured both the judges’ top honor and the audience’s vote, signaling strong industry confidence in its potential. Lactoferrin, a multifaceted protein found naturally in human milk, is renowned for its immune-modulating and antimicrobial properties. Helaina’s proprietary precision fermentation technology enables the production of a bioidentical human lactoferrin, offering a distinct advantage in terms of efficacy and bioavailability compared to animal-derived sources.
The presentation highlighted compelling research, including a study preprint that underscores effera’s capacity to fortify the integrity of the gut epithelial barrier. A robust ex vivo adult model study further demonstrated effera’s positive impact on the gut microbiome, notably its ability to enhance acetate production, a crucial short-chain fatty acid with broad health implications. Dan DeMarino, VP of Commercial at Helaina, emphasized the transformative nature of their innovation, remarking, "We are at a new frontier in human health. We have precision fermentation and we have the ability to make human bioactives that we didn’t have access to before." This breakthrough in producing human bioactives via precision fermentation is poised to redefine the biotics market, moving beyond traditional probiotics to offer targeted, human-specific solutions. The implications extend to enhanced immune function, improved digestive health, and potentially even applications in infant nutrition and wound healing, positioning effera as a highly versatile and impactful ingredient. The industry is closely watching Helaina’s next steps as they prepare to bring this groundbreaking ingredient to a wider market.
Longevity Winner: Kinexa Joint Longevity Complex Targets Mobility and Quality of Life
In the rapidly expanding longevity category, Kinexa Joint Longevity Complex, developed by PLT Health Solutions, was awarded the judges’ top prize, recognizing its innovative approach to supporting joint health and promoting an active lifestyle well into aging. While all three finalists in this category shared the audience’s applause, the expert panel ultimately bestowed the Ingredient Idol title upon Kinexa for its unique botanical synergy and promising clinical data.
Kinexa is a meticulously crafted blend of three potent botanicals: turmeric (Curcuma longa), Indian frankincense (Boswellia serrata), and Haritaki (Terminalia chebula). This synergistic combination is designed to address multiple facets of joint health, including inflammation, stiffness, and discomfort. The presentation included compelling evidence from research utilizing magnetic resonance imaging (MRI) to demonstrate Kinexa’s efficacy in improving knee strength and mitigating stiffness and discomfort. Although a full clinical trial is pending publication, the preliminary findings presented at SupplySide Global 2026 have generated significant excitement within the scientific and consumer communities.
Jeremy Appleton, N.D., Director of Medical and Scientific Affairs at PLT Health Solutions, expressed the company’s vision for Kinexa, stating, "We really hope that Kinexa will change the conversation about what a longevity ingredient can deliver." This sentiment underscores the growing demand for ingredients that not only extend lifespan but also enhance healthspan, enabling individuals to maintain an active and fulfilling life. The multi-botanical approach of Kinexa offers a holistic solution for joint health, appealing to consumers seeking natural and comprehensive support. The ingredient’s potential to significantly improve quality of life for aging populations positions it as a key player in the burgeoning longevity market. Industry observers anticipate that Kinexa’s success will inspire further research into botanical combinations for age-related health concerns.
Event Context and Industry Significance
SupplySide Global serves as a crucial nexus for the dietary supplement, functional food, and beverage industries, bringing together manufacturers, suppliers, researchers, and formulators from around the world. The event provides a vital platform for networking, knowledge exchange, and the unveiling of next-generation products and technologies. The Ingredient Idol competition, a highlight of the annual event, serves as a barometer for emerging trends and a catalyst for innovation. By focusing on high-growth categories such as adaptogens, biotics, and longevity, SupplySide Global 2026 underscored the industry’s strategic direction and its commitment to addressing evolving consumer health priorities.
The success of Xeya Modern Shatavari, effera Lactoferrin, and Kinexa Joint Longevity Complex at this year’s competition reflects a broader industry shift towards scientifically validated, highly standardized, and innovative ingredients. The emphasis on precision fermentation for effera, the potent standardization of Xeya, and the synergistic botanical approach of Kinexa all exemplify the sophisticated research and development driving the modern supplement landscape. These ingredients are not merely standalone products; they represent the future of personalized nutrition and preventative health, offering targeted solutions for complex health challenges. The implications for the broader health and wellness market are substantial, promising a new generation of dietary supplements that are more effective, more targeted, and more aligned with the scientific understanding of human physiology. As these award-winning ingredients move from the competition stage to commercial availability, their impact is expected to ripple through product development pipelines and consumer choices, further shaping the trajectory of the global health and wellness industry.
